These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 26827491)
1. [FUNCTIONAL ACTIVITY OF THE BRAIN INSULIN SIGNALING SYS TEM IN NORM AND IN TYPE 2 DIABETES MELLITUS]. Shpakov AO Ross Fiziol Zh Im I M Sechenova; 2015 Oct; 101(10):1103-27. PubMed ID: 26827491 [TBL] [Abstract][Full Text] [Related]
2. [THE BRAIN LEPTIN SIGNALING SYSTEM AND ITS FUNCTIONAL STATE IN METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITIS]. Shpakov AO Zh Evol Biokhim Fiziol; 2016 Mar; 52(2):161-176. PubMed ID: 30695496 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis. Chen W; Balland E; Cowley MA Neuroendocrinology; 2017; 104(4):364-381. PubMed ID: 28122381 [TBL] [Abstract][Full Text] [Related]
4. [The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the transition of impaired glucose tolerance to overt type 2 diabetes mellitus]. Shpakov AO Tsitologiia; 2014; 56(11):789-99. PubMed ID: 25707205 [TBL] [Abstract][Full Text] [Related]
5. [FUNCTIONAL STATE OF THE HYPOTHALAMIC SIGNALING SYSTEMS IN RATS WITH TYPE 2 DIABETES MELLITUS TREATED WITH INTRANASAL INSULIN]. Sukhov IB; Derkach KV; Chistyakova OV; Bondareva VM; Shpakov AO Zh Evol Biokhim Fiziol; 2016 Mar; 52(2):184-194. PubMed ID: 30695498 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Zhao WQ; Townsend M Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743 [TBL] [Abstract][Full Text] [Related]
10. [The functioning of hormone-sensitive adenylyl cyclase system in the peripheral tissiues in diabetes mellitus]. Shpakov AO; Derkach KV Tsitologiia; 2014; 56(2):91-104. PubMed ID: 25509148 [TBL] [Abstract][Full Text] [Related]
11. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status. Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833 [TBL] [Abstract][Full Text] [Related]
12. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications. Tumminia A; Vinciguerra F; Parisi M; Frittitta L Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995 [TBL] [Abstract][Full Text] [Related]
13. [The functional state of biogenic amines- and acetylcholine-regulated signaling systems of the brain in diabetes mellitus]. Shpakov AO Tsitologiia; 2012; 54(6):459-68. PubMed ID: 22997730 [TBL] [Abstract][Full Text] [Related]
14. Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period? Das UN J Nutr Biochem; 2007 Nov; 18(11):701-13. PubMed ID: 17475465 [TBL] [Abstract][Full Text] [Related]
15. [Effects of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in the myocardium, ovaries, and uterus of rats with prolonged neonatal model of diabetes mellitus]. Shpakov AO; Derkach KV; Chistiakova OV; Moĭseiuk IV; Sukhov IB; Bondareva VM Zh Evol Biokhim Fiziol; 2013; 49(2):118-27. PubMed ID: 23789397 [TBL] [Abstract][Full Text] [Related]
16. [Dementia and diabetes: casual or causal relationship?]. Formiga F; Reñe R; Pérez-Maraver M Med Clin (Barc); 2015 Feb; 144(4):176-80. PubMed ID: 24629693 [TBL] [Abstract][Full Text] [Related]
17. Central infusion of ketone bodies modulates body weight and hepatic insulin sensitivity by modifying hypothalamic leptin and insulin signaling pathways in type 2 diabetic rats. Park S; Kim DS; Daily JW Brain Res; 2011 Jul; 1401():95-103. PubMed ID: 21652033 [TBL] [Abstract][Full Text] [Related]
18. Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Shpakov AO; Derkach KV; Berstein LM Future Sci OA; 2015 Nov; 1(3):FSO25. PubMed ID: 28031898 [TBL] [Abstract][Full Text] [Related]
19. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes. Kasibhatla B; Wos J; Peters KG Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056 [TBL] [Abstract][Full Text] [Related]
20. The impairment of insulin signaling in Alzheimer's disease. Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]